Abstract:The aim of this study is to examine the influence on biodistribution by introducing the [ 99m Tc≡N] 2+ core into the complex so as to explore a new radiopharmaceutical. 99m TcN-IBDTC (IBDTC:N-isobutyl dithiocarbamate) was prepared through a two-step ligand-exchange reaction by using SnCl 2·2H 2O as reduction agent and SDH (succinic dihydrazide) as a donor of nitride nitrogen atom (N 3- ) at room temperature. The ligand IBDTC was labelled with 99m TcO - 4 directly by using FSA (Formamidine sulfinic acid) as reducing agent. The radiochemical purity of the 99m TcN-IBDTC and 99m Tc-IBDTC complex were both over 90% by TLC. The biodistribution results in mice indicated that 99m TcN-IBDTC had high brain uptake and good brain retention. The brain uptake (%ID·g -1 ) was 6.22, 5.45 and 3.88 and the brain/blood ratios were 1.51, 2.24 and 1.84 at 5, 30 and 60min post-injection respectively. The results suggested that it would be potentially useful as a brain perfusion imaging agent. 99m TcN-IBDTC also exhibited high myocardial uptake, but the washout from the heart was rapid and the heart/liver ratio was low thereby restricting the use of the complex as a myocardial perfusion imaging agent. The biodistribution results in mice suggested 99m Tc-IBDTC was mostly accumulated in liver, whereas the brain and heart uptake was very low. This study proves that the introduction of the [ 99m Tc≡N] 2+ core into the molecular structure of a radiopharmaceutical may obviously alter its biological behavior. This may be valuable for the design of new radiopharmaceuticals for clinical use.

Preparation and Biodistribution of the 99mTcN-CPDTC Complex as a New Potential Brain Perfusion Imaging Agent

Synthesis and Biodistribution Of99mtcn(pdtc)2as a Potential Brain Imaging Agent

Synthesis, Characterization and Biodistribution of A99mtc Nitrido Complex As a Potential Brain Perfusion Imaging Agent

Synthesis and biodistribution of a new 99mTc nitrido complex for cerebral imaging

Preparation of 99mtcn(cbdtc)2 and Its Biodistribution in Mice.

Synthesis and Biodistribution of Two Novel 99m Tc Nitrido Dithiocarbamate Complexes Containing Heterocyclic Linkage As Potential Brain Perfusion Imaging Agents

Synthesis and Biodistribution of a New 99mtc Nitrido Complex for Brain Imaging

Synthesis of a Bis-(N-sec-butyl-dithiocarbamato)-nitrido-99mtc Complex: a Potential New Radiopharmaceutical for Brain Perfusion Studies

Synthesis and Biodistribution of a Novel 99mtc Nitrido Dithiocarbamate Complex Containing Aromatic Group for Cerebral Imaging

Synthesis and biodistribution of a novel [99mTcN(PNP5)(DMCHDTC)]+ complex as a potential myocardial perfusion imaging agent.

Synthesis and biodistribution of the 99m Tc(CO) 3 -DEDT complex as a potential new radiopharmaceutical for brain imaging

Preparation of New Technetium-99m Nns/X Complexes and Selection for Brain Imaging Agent

Synthesis And Biodistribution Of A Novel [(Tcn)-Tc-99m(Pnp5)(Dmchdtc)](+) Complex As A Potential Myocardial Perfusion Imaging Agent

Synthesis and biodistribution of 99m TcN(CHIPDTC) 2 as a potential myocardial perfusion imaging agent

Synthesis and biodistribution of a novel 99m Tc nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent

[99Mtcn(pnp5)(noet)]+: A Novel Potential Myocardial Perfusion Imaging Agent

A Study of Comparison Between 99Mtcn-Ibdtc and 99Mtc-Ibdtc

Preparation and Prelminary Biodistribution in Mice of 99Mtcn-Bmpbda for Myocardial Perfusion Imaging

Preparation of 99mTc-nitrido asymmetrical heterocomplex with 4-(cyclohexylpiperazin-1-yl)-dithioformate and its biological evaluation as a potential myocardial imaging agent.

Synthesis of New N2S Ligands, Preparation of 99mtc Complexes and Their Preliminary Biodistribution in Mice

Synthesis and Evaluation of 99Mtc–2-[(3-carboxy-1-oxopropyl)amino]-2-deoxy-d-glucose As a Potential Tumor Imaging Agent